SynthesisFrontiers in public health2021

SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Nanjing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.